Latest Articles
In-Office Nitrous Oxide Linked to Fewer OR Ob/Gyn Procedures - Medscape
In-Office Nitrous Oxide Linked to Fewer OR Ob/Gyn Procedures Medscape
Published: May 14, 2026, 1:22 p.m.
Maipl Therapeutics Reports Preclinical Progress for MA-4604, a Novel Oral Non-Hormonal Treatment of Endometriosis - Newswise
Maipl Therapeutics Reports Preclinical Progress for MA-4604, a Novel Oral Non-Hormonal Treatment of Endometriosis Newswise
Published: May 14, 2026, 12:40 p.m.
Karyopharm Therapeut Reports Q1 2026: $35.1M Revenue, $29.2M U.S. Product Sales, Net Loss $22.4M - TradingView
Karyopharm Therapeut Reports Q1 2026: $35.1M Revenue, $29.2M U.S. Product Sales, Net Loss $22.4M TradingView
Published: May 14, 2026, 11:33 a.m.
Karyopharm Reports First Quarter 2026 Financial Results and Completion of Phase 3 Endometrial Cancer Trial Enrollment - PR Newswire
Karyopharm Reports First Quarter 2026 Financial Results and Completion of Phase 3 Endometrial Cancer Trial Enrollment PR Newswire
Published: May 14, 2026, 11:30 a.m.
Press Release: Karyopharm Reports First Quarter 2026 Financial Results and Completion of Phase 3 Endometrial Cancer Trial Enrollment - Moomoo
Press Release: Karyopharm Reports First Quarter 2026 Financial Results and Completion of Phase 3 Endometrial Cancer Trial Enrollment Moomoo
Published: May 14, 2026, 11:30 a.m.
Shalimar from Uttar Pradesh Receives JM Financial Hurun Founders Awards 2026 - businessnewsthisweek.com
Shalimar from Uttar Pradesh Receives JM Financial Hurun Founders Awards 2026 businessnewsthisweek.com
Published: May 14, 2026, 8:05 a.m.
Robert Irwin praises sister Bindi’s bravery amid gala absence - MSN
Robert Irwin praises sister Bindi’s bravery amid gala absence MSN
Published: May 14, 2026, 2:18 a.m.
Robert Irwin praises his "brave" sister Bindi amidst health battle after she misses gala - New Idea
Robert Irwin praises his "brave" sister Bindi amidst health battle after she misses gala New Idea
Published: May 14, 2026, 2:07 a.m.
GenCurix, a precision medical diagnostic company, announced on the 14th that the results of a study - 매일경제
GenCurix, a precision medical diagnostic company, announced on the 14th that the results of a study 매일경제
Published: May 14, 2026, 1:07 a.m.
Preliminary Evaluation of Leuprorelin Acetate Microspheres Plus Levonorgestrel-Releasing Intrauterine System in Endometriosis: An Exploratory Study Focusing on BNIP3 and EPAC1 Expression.
This exploratory pilot study aimed to assess the preliminary clinical effects of leuprorelin acetate microspheres for injection [gonadotropin-releasing hormone agonist (GnRH-a)] combined with levonorgestrel-releasing intrauterine system (LNG-IUS) in treating endometriosis …
Published: May 14, 2026, midnight
Link copied to clipboard!